Ocular pseudomyasthenia or ocular my asthenia 'plus'
- 1 September 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 39 (9) , 1150
- https://doi.org/10.1212/wnl.39.9.1150
Abstract
Myasthenia gravis (MG) commonly presents with weakness and fatigability of the lids and extraocular muscles, which respond to treatment with anticholinesterase medication. However, certain intracranial mass lesions may mimic these features of MG; alternatively, MG may mask the signs of a coexistent intracranial mass. We describe 8 patients originally diagnosed as having MG by knowledgeable clinicians, in whom an intracranial lesion instead of, or in addition to, MG was later identified. The lesions included parasellar tumors and aneurysms. In patients presenting with clinical features of ocular MG, it is therefore essential to establish a definite diagnosis of MG, to exclude other possible causes of "pseudomyasthenia," and to exclude other diseases that might be masked by coexisting myasthenic weakness. We recommend that patients with clinical features of MG limited to the ocular or cranial musculature be thoroughly evaluated for intracranial mass lesions, using CT or MRI if warranted.This publication has 5 references indexed in Scilit:
- Seronegative myasthenia gravisNeurology, 1988
- Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravisJournal of Neuroimmunology, 1985
- Antibody to acetylcholine receptor in myasthenia gravisNeurology, 1976
- Prostigmine‐Responsiveness and the Diagnosis of Myasthenia GravisNeurology, 1955